Clinical Trials on C. Diff Colitis

Total 4533 results

Lumen Bioscience, Inc.

Completed

Exploratory Study to Assess Delivery of LMN-201 Components Via Enteric Capsules in the Gut of Individuals With Ostomies

C. Diff. Infections

Australia
University of Pittsburgh
MucoVax, BV, the Netherlands

Terminated

Whey Protein Concentrate 40% Made of Milk of Immunized Cows to Aid in the Prevention of Relapse of Clostridium Difficile-Diarrhea

Positive C-Diff Culture

United States
Finch Research and Development LLC.
Medpace, Inc.

Completed

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection (PRISM-EXT)

Clostridium Difficile Infection | Recurrent Clostridium Difficile Infection | C. Diff | CDI | Recurrent C. Diff | rCDI | C. Difficile | Recurrent CDI | FMT | Fecal Microbiota | Fecal Transplant

United States, Canada
University of Wisconsin, Madison
Mayo Clinic; Medical College of Wisconsin; Agency for Healthcare Research and... and other collaborators

Completed

Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection

Clostridium Difficile Infection | Recurrent Clostridium Difficile Infection | CDI | C.Difficile Diarrhea | C. Diff Colitis | C.Difficile Colitis

United States
David Binion, MD
Merck Sharp & Dohme LLC

Recruiting

Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis | C. Diff. Infections

United States
Baylor College of Medicine
Michael E. DeBakey VA Medical Center

Enrolling by invitation

Defined Fecal Microbiota Transplantation for Clostridium Difficile Diarrhea

Active C. Difficile Colitis

United States
Maastricht University Medical Center

Completed

Case-Control Study to Identify Risk Factors for Microscopic Colitis

Lymphocytic Colitis | Microscopic Colitis | Collagenous Colitis

Netherlands
University of Wisconsin, Madison
Agency for Healthcare Research and Quality (AHRQ)

Enrolling by invitation

FQ Restriction for the Prevention of CDI (FIRST)

Clostridium Difficile Infection | Clostridium Difficile | C Difficile Colitis

United States
Dr. Falk Pharma GmbH

Completed

Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis

Lymphocytic Colitis

Germany
Technische Universität Dresden
Dr. Falk Pharma GmbH

Completed

Budesonide Treatment for Lymphocytic Colitis

Microscopic Colitis

Germany
Dr. Falk Pharma GmbH
The Swedish Organization for Studies on Inflammatory Bowel Disease

Completed

SOIBD Collagenous Colitis Maintenance Study (SCCMS)

Induction and Maintaining Remission of Collagenous Colitis

Germany, Sweden
Karolinska University Hospital

Unknown

Usefulness of Chromoendoscopy in Diagnosing Microscopic Colitis

Lymphocytic Colitis | Collagenous Colitis | Chronic Diarrhoea

Sweden
Dr. Falk Pharma GmbH

Completed

Budesonide for Induction of Remission in Incomplete Microscopic Colitis

Incomplete Microscopic Colitis

Germany, Sweden
Dr. Falk Pharma GmbH

Completed

Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis

Collagenous Colitis

Germany
Technische Universität Dresden
AstraZeneca

Completed

Budesonide for Maintenance Treatment of Collagenous Colitis

Collagenous Colitis

Germany
Bonderup, Ole K., M.D.

Unknown

Rifaximin-treatment of Collagenous Colitis (XiCoCo)

Collagenous Colitis
Bonderup, Ole K., M.D.
AstraZeneca

Unknown

Long-Term Treatment of Collagenous Colitis With Budesonide

Collagenous Colitis

Denmark
Hvidovre University Hospital

Not yet recruiting

Faecal Microbiota Transplantation for Microscopic Colitis

Microscopic Colitis
Eugene F Yen, MD

Recruiting

Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis

Microscopic Colitis

United States
Örebro University, Sweden
Region Örebro County

Completed

Faecal Microbiota Transplantation in Patients With Microscopic Colitis

Microscopic Colitis

Sweden
Ferring Pharmaceuticals

Completed

Canadian Active & Maintenance Modified Pentasa Study (CAMMP)

Active Ulcerative Colitis | Remission of Ulcerative Colitis

Canada
Palatin Technologies, Inc

Recruiting

Phase 2a To Evaluate PL-8177 in Subjects With Active Ulcerative Colitis (UC) (PL8177-205)

Ulcerative Colitis | Ulcerative Colitis Flare | Ulcerative Colitis Acute | Ulcerative

United States
Theravance Biopharma

Completed

TD-1473 for Active Ulcerative Colitis (UC)

Ulcerative Colitis, Active Severe | Ulcerative Colitis, Active Moderate

United States, Georgia, Moldova, Republic of, Romania
Rise Therapeutics LLC
University of Colorado, Denver; Mayo Clinic

Recruiting

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

Ulcerative Colitis | Ulcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic | Ulcerative Colitis Chronic Mild

United States
Meharry Medical College

Not yet recruiting

Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD

Inflammatory Bowel Diseases | Ulcerative Colitis | Crohn Colitis | Indeterminate Colitis

United States
Shaare Zedek Medical Center

Completed

Manipulating the Microbiome in IBD by Antibiotics and FMT (FMT)

Exacerbation of Ulcerative Colitis | Ulcerative Colitis, Active Severe | Crohn's Colitis

Israel, Italy, Canada, Finland, Poland, Spain
University of Calgary
Ferring Pharmaceuticals

Not yet recruiting

Efficacy and Safety of Budesonide MMX® vs. Budesonide CR for Induction of Remission in Microscopic Colitis

Microscopic Colitis
Assistance Publique - Hôpitaux de Paris
MRSU 938 - Research Center of Saint Antoine

Not yet recruiting

Oral Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis (T-FORE)

Pediatric Ulcerative Colitis in Remission

France
Protagonist Therapeutics, Inc.

Completed

PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)

Ulcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic Severe

United States, Austria, Bulgaria, Canada, Georgia, Germany, Hungary, Italy, Korea, Republic of, Poland, Russian Federation, Serbia, Ukraine
Theravance Biopharma

Completed

TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC)

Active Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy Subjects

United States
Altheus Therapeutics, Inc.

Unknown

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Ulcerative Colitis | Left-sided Ulcerative Colitis | Distal Ulcerative Colitis

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...
University Medical Center Groningen; UMC Utrecht

Recruiting

Transfer of Feces in Ulcerative Colitis 2 (TURN2)

Ulcerative Colitis | Ulcerative Colitis Flare | Ulcerative Colitis Acute

Netherlands
Immune Pharmaceuticals

Unknown

Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis

Ulcerative Colitis, Active Severe | Ulcerative Colitis, Active Moderate

Israel
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGET (In-TARGET)

ULCERATIVE COLITIS

France, Belgium
Xijing Hospital of Digestive Diseases

Not yet recruiting

Autologous Platelet-rich Plasma (PRP) and Thrombin Coagulum for the Topical Treatment of Rectal Mucosal Ulcers

Ulcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic Severe | Rectal Ulcer

China
Maastricht University Medical Center

Completed

Ussing Experiments to Evaluate the Role of Medication-induced Microscopic Colitis

Microscopic Colitis

Netherlands
University Medical Center Nijmegen

Unknown

Clinical Outcome After Close Rectal Ileo Pouch Anal Anastomosis for Colitis Ulcerosa(CU) (CR-IPAA)

Ulcerative Colitis

Netherlands
AbbVie

Not yet recruiting

A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis

Ulcerative Colitis (UC)

United States, Puerto Rico
Hamilton Health Sciences Corporation
Canadian Institutes of Health Research (CIHR)

Not yet recruiting

Screening Donors, Fecal Microbiota Transplant Program in Ulcerative Colitis (FUEL)

Ulcerative Colitis Flare

Canada
TLA, Targeted Immunotherapies AB

Recruiting

Dose-Evaluation Study of the Efficacy and Safety of TLA Gut™ Leukapheresis Treatment in Patients With Ulcerative Colitis

Ulcerative Colitis (UC)

Sweden
AbbVie

Active, not recruiting

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Ulcerative Colitis (UC)

United States, Australia, Austria, Belgium, Canada, Croatia, Denmark, France, Germany, Greece, Ireland, Israel, Italy, Mexico, Netherlands, New Zealand, Norway, Puerto Rico, Spain, Sweden, United Kingdom
Theravance Biopharma

Terminated

Efficacy & Safety of TD-1473 in Ulcerative Colitis (RHEA)

Ulcerative Colitis (UC)

United States, Australia, Bulgaria, Canada, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Poland, Portugal, Romania, Serbia, Slovakia, South Africa, Spain, Taiwan, Ukraine
AbbVie

Completed

Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis

Ulcerative Colitis (UC)

United States, Austria, Belgium, Canada, Czechia, Denmark, France, Germany, Hungary, Israel, Italy, Japan, Netherlands, Poland, Romania, Slovakia, Spain, Switzerland, Ukraine, United Kingdom
Dr. Falk Pharma GmbH

Completed

TID 1000 mg Mesalazine Versus TID 2x500 mg Mesalazine in Active Ulcerative Colitis (UC)

Active Ulcerative Colitis

Germany
Wolfson Medical Center

Not yet recruiting

Combination of Diet and Oral Budesonide for Ulcerative Colitis (ReDUCE)

Ulcerative Colitis | Ulcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic Mild

Israel, Switzerland, Italy, Netherlands
IRCCS San Raffaele

Recruiting

Comparison Between Bowel Ultrasound-based Treat to Target Versus Routine Treat to Target Strategies in Ulcerative Colitis

Ulcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic Severe

Italy
Oncostellae S.L

Completed

Study of OST-122 in Patients With Moderate to Severe Ulcerative Colitis

Ulcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic Severe

Spain, Ukraine
Assembly Biosciences

Terminated

ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis

Ulcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic Mild

United States, Canada
Dayanand Medical College and Hospital
Colitis & Crohn's Foundation (India)

Unknown

Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC

Ulcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic Mild

India
Norwegian University of Science and Technology
AstraZeneca

Terminated

Treatment of Microscopic Colitis

Colitis

Norway

Clinical Trials on C. Diff Colitis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations